Skip to content

Supplier News

Camber releases Cymbalta generic

Camber releases Cymbalta generic

Camber Pharmaceuticals has launched duloxetine 20-, 30- and 60-mg capsules, a medication for depression and anxiety. Camber said Tuesday that its product, a generic version of Cymbalta capsules from Eli Lilly and Co.

Perrigo licenses meth-resistant tech for PSE products

Perrigo licenses meth-resistant tech for PSE products

Perrigo Co. plc is bringing in methamphetamine-blocking capability for pseudoephedrine (PSE) products. On Tuesday, Perrigo said it has entered an exclusive licensing agreement with St. Louis-based Highland Pharmaceuticals for its Tarex meth-blocking technology.

CEO succession at Endo

CEO succession at Endo

Endo International plc has appointed Paul Campanelli, as president and chief executive officer, succeeding Rajiv De Silva, who is stepping down. Endo said Campanelli, who was president of its generic drugs and OTC business, takes the helm as president and CEO effective immediately.

Fred’s pharmacy executive joins Ateb

Fred’s pharmacy executive joins Ateb

Shannon Strickland, a senior vice president for Fred’s Pharmacy, has been hired by Ateb Inc. as vice president of pharmacy execution. Ateb said Thursday that Strickland will lead its independent sales team and select pharmacy chains.

PhRMA gathers scientists on Capitol Hill

PhRMA gathers scientists on Capitol Hill

The Pharmaceutical Research and Manufacturers of America (PhRMA) yesterday brought more than 60 researchers and scientists from its member companies to meet with congressional lawmakers.

KVK Tech weight-loss drug Lomaira approved

KVK Tech weight-loss drug Lomaira approved

KVK Tech Inc. plans to release Lomaira tablets, a short-term, low-dose prescription medicine for weight loss, by the end of this month. KVK said Tuesday that Lomaira (phentermine hydrochloride 8-mg tablets CIV) gained approval from the Food and Drug Administration.